Emendo Biotherapeutics

DNA Correction and Genome-editing Platforms

Active Acquired Startup Acquired Founded 2015-05

Emendo Biotherapeutics develops next-generation gene-editing tools for genetic disorders, addressing technological gaps for realizing the promise of gene therapy. Emendo genome-editing technology can repair and eliminate genetic mutations in living cells that cause serious diseases or disorders. Emendo's gene-editing solutions are recombination based, highl…

SectorHealth Tech & Life Sciences
StageAcquired
Total raised$73.0M
Employees42
Founded2015-05
HQ
Patents1
Confidence90
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals